Simulating the hydrodynamic conditions in the united states pharmacopeia paddle dissolution apparatus

The objective of this work was to examine the feasibility of developing a high-performance computing software system to simulate the United States Pharmacopeia (USP) dissolution apparatus 2 (paddle apparatus) and thus aid in characterizing the fluid hydrodynamics in the method. The USP apparatus was modeled using the hydrodynamic package Fluent. The Gambit program was used to create a “wireframe” of the apparatus and generate the 3-dimensional grids for the computational fluid dynamics solver. The Fluent solver was run on an IBM RS/6000 SP distributed memory parallel processor system, using 8 processors. Configurations with and without a tablet present were developed and examined. Simulations for a liquid-filled vessel at a paddle speed of 50 rpm were generated. Large variations in fluid velocity magnitudes with position in the vessel were evident. Fluid velocity predictions were in good agreement with those previously published, using laser Doppler velocity measurements. A low-velocity domain was evident directly below the center of the rotating paddle. The model was extended to simulate the impact of the presence of a cylindrical tablet in the base of the dissolution vessel. The presence of the tablet complicated the local fluid flow, and large fluid shear rates were evident at the base of the compact. Fluid shear rates varied depending on the tablet surface and the location on the surface and were consistent with the reported asymmetrical dissolution of model tablets. The approach has the potential to explain the variable dissolution results reported and to aid in the design/prediction of optimal dissolution conditions for in vitro-in vivo correlations.

[1]  IN VITRO STUDIES ON THE DISSOLUTION AND ABSORPTION BEHAVIOUR OF ORALLY ADMINISTERED DRUGS, AND THE CONNECTION TO THEIR BIOAVAILABILITY , 1976 .

[2]  A. Beckett,et al.  Improved Hydrodynamics for USP Apparatus 2 , 1996 .

[3]  Dissolution assay development for in vitro-in vivo correlations. Theory and case studies. , 1997, Advances in experimental medicine and biology.

[4]  G. J. Morris,et al.  Fluid and Particle Laser Doppler Velocity Measurements and Mass Transfer Predictions for the Usp Paddle Method Dissolution Apparatus , 1990 .

[5]  A. Healy,et al.  Sensitivity of dissolution rate to location in the paddle dissolution apparatus , 2002, The Journal of pharmacy and pharmacology.

[6]  A. Weiss,et al.  Aspirin and gastric bleeding. Gastroscopic observations, with review of literature. , 1961, The American journal of medicine.

[7]  A. King,et al.  Systematic error associated with apparatus 2 of the USP dissolution test II: Effects of deviations in vessel curvature from that of a sphere. , 1982, Journal of pharmaceutical sciences.

[8]  D. Viswanath,et al.  Data book on the viscosity of liquids , 1989 .

[9]  Gerhard Levy,et al.  Effect of Certain Tablet Formulation Factors on Dissolution Rate of the Active Ingredient I11 , 1963 .

[10]  Gerhard Levy,et al.  Development of In Vitro Dissolution Tests which Correlate Quantitatively with Dissolution Rate-Limited Drug Absorption in Man , 1965 .

[11]  J. Dressman,et al.  Influence of Hydrodynamics and Particle Size on the Absorption of Felodipine in Labradors , 2004, Pharmaceutical Research.

[12]  S. Qureshi,et al.  Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[13]  Y. Seta,et al.  Comparison of the mechanical destructive force in the small intestine of dog and human. , 2002, International journal of pharmaceutics.

[14]  G. Levy EFFECT OF CERTAIN TABLET FORMULATION FACTORS ON DISSOLUTION RATE OF THE ACTIVE INGREDIENT. I. IMPORTANCE OF USING APPROPRIATE AGITATION INTENSITIES FOR IN VITRO DISSOLUTION RATE MEASUREMENTS TO REFLECT IN VIVO CONDITIONS. , 1963, Journal of pharmaceutical sciences.

[15]  S. Qureshi,et al.  Cause of high variability in drug dissolution testing and its impact on setting tolerances. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.